186 related articles for article (PubMed ID: 33254531)
1. Can hyperbaric oxygen safely serve as an anti-inflammatory treatment for COVID-19?
Kjellberg A; De Maio A; Lindholm P
Med Hypotheses; 2020 Nov; 144():110224. PubMed ID: 33254531
[TBL] [Abstract][Full Text] [Related]
2. Physiologic and biochemical rationale for treating COVID-19 patients with hyperbaric oxygen.
Feldmeier JJ; Kirby JP; Buckey JC; Denham DW; Evangelista JS; Gelly HB; Harlan NP; Mirza ZK; Ray KL; Robins M; Savaser DJ; Wainwright S; Bird N; Huang ET; Moon RE; Thom SR; Weaver LK
Undersea Hyperb Med; 2021; 48(1):1-12. PubMed ID: 33648028
[TBL] [Abstract][Full Text] [Related]
3. Hyperbaric oxygen therapy may be effective to improve hypoxemia in patients with severe COVID-2019 pneumonia: two case reports.
Guo D; Pan S; Wang M; Guo Y
Undersea Hyperb Med; 2020; 47(2):181-187. PubMed ID: 32574433
[TBL] [Abstract][Full Text] [Related]
4. Hyperbaric oxygen as an adjuvant treatment for patients with COVID-19 severe hypoxaemia: a randomised controlled trial.
Cannellotto M; Duarte M; Keller G; Larrea R; Cunto E; Chediack V; Mansur M; Brito DM; García E; Di Salvo HE; Verdini F; Domínguez C; Jorda-Vargas L; Roberti J; Di Girolamo G; Estrada E
Emerg Med J; 2022 Feb; 39(2):88-93. PubMed ID: 34907003
[TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H
Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427
[TBL] [Abstract][Full Text] [Related]
7. Hyperbaric oxygen for COVID-19 patients with severe hypoxia prior to vaccine availability.
Jansen D; Dickstein DR; Erazo K; Stacom E; Lee DC; Wainwright SK
Undersea Hyperb Med; 2022; 49(3):295-305. PubMed ID: 36001562
[TBL] [Abstract][Full Text] [Related]
8. UHMS Position Statement: Hyperbaric Oxygen (HBO2) for COVID-19 Patients.
Undersea Hyperb Med; 2020; 47(2):297-298. PubMed ID: 32574446
[TBL] [Abstract][Full Text] [Related]
9. Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV): A structured summary of a study protocol for a randomised controlled trial.
Declercq J; Bosteels C; Van Damme K; De Leeuw E; Maes B; Vandecauter A; Vermeersch S; Delporte A; Demeyere B; Vuylsteke M; Lalla M; Smart T; Detalle L; Bouw R; Streffer J; Degeeter T; Vergotte M; Guisez T; Van Braeckel E; Van Der Straeten C; Lambrecht BN
Trials; 2020 Nov; 21(1):934. PubMed ID: 33213529
[TBL] [Abstract][Full Text] [Related]
10. Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes.
Taghavi-Farahabadi M; Mahmoudi M; Soudi S; Hashemi SM
Med Hypotheses; 2020 Nov; 144():109865. PubMed ID: 32562911
[TBL] [Abstract][Full Text] [Related]
11. Could pulmonary low-dose radiation therapy be an alternative treatment for patients with COVID-19 pneumonia? Preliminary results of a multicenter SEOR-GICOR nonrandomized prospective trial (IPACOVID trial).
Arenas M; Algara M; De Febrer G; Rubio C; Sanz X; de la Casa MA; Vasco C; Marín J; Fernández-Letón P; Villar J; Torres-Royo L; Villares P; Membrive I; Acosta J; López-Cano M; Araguas P; Quera J; Rodríguez-Tomás F; Montero A
Strahlenther Onkol; 2021 Nov; 197(11):1010-1020. PubMed ID: 34230996
[TBL] [Abstract][Full Text] [Related]
12. Hyperbaric oxygen therapy for COVID-19 patients with respiratory distress: treated cases versus propensity-matched controls.
Gorenstein SA; Castellano ML; Slone ES; Gillette B; Liu H; Alsamarraie C; Jacobson AM; Wall SP; Adhikari S; Swartz JL; McMullen JJS; Osorio M; Koziatek CA; Lee DC
Undersea Hyperb Med; 2020; 47(3):405-413. PubMed ID: 32931666
[TBL] [Abstract][Full Text] [Related]
13. Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19.
Kjellberg A; Douglas J; Pawlik MT; Kraus M; Oscarsson N; Zheng X; Bergman P; Frånberg O; Kowalski JH; Nyren SP; Silvanius M; Skold M; Catrina SB; Rodriguez-Wallberg KA; Lindholm P
BMJ Open; 2021 Jul; 11(7):e046738. PubMed ID: 34226219
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics.
Qin H; Zhao A
Protein Cell; 2020 Oct; 11(10):707-722. PubMed ID: 32519302
[TBL] [Abstract][Full Text] [Related]
15. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
Elife; 2020 Apr; 9():. PubMed ID: 32338605
[TBL] [Abstract][Full Text] [Related]
16. Hyperbaric oxygen as a treatment for COVID-19 infection?
Moon RE; Weaver LK
Undersea Hyperb Med; 2020; 47(2):177-179. PubMed ID: 32574432
[TBL] [Abstract][Full Text] [Related]
17. Acute respiratory distress syndrome (ARDS) caused by the novel coronavirus disease (COVID-19): a practical comprehensive literature review.
Montenegro F; Unigarro L; Paredes G; Moya T; Romero A; Torres L; López JC; González FEJ; Del Pozo G; López-Cortés A; Diaz AM; Vasconez E; Cevallos-Robalino D; Lister A; Ortiz-Prado E
Expert Rev Respir Med; 2021 Feb; 15(2):183-195. PubMed ID: 32902367
[TBL] [Abstract][Full Text] [Related]
18. Hyperbaric oxygen therapy to treat lingering COVID-19 symptoms.
Zant AE; Figueroa XA; Paulson CP; Wright JK
Undersea Hyperb Med; 2022; 49(3):333-339. PubMed ID: 36001566
[TBL] [Abstract][Full Text] [Related]
19. A prospective trial of hyperbaric oxygen for chronic sequelae after brain injury (HYBOBI).
Churchill S; Weaver LK; Deru K; Russo AA; Handrahan D; Orrison WW; Foley JF; Elwell HA
Undersea Hyperb Med; 2013; 40(2):165-93. PubMed ID: 23682548
[TBL] [Abstract][Full Text] [Related]
20. Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial.
Mazeraud A; Gonçalves B; Aegerter P; Mancusi L; Rieu C; Bozza F; Sylla K; Siami S; Sharshar T
Trials; 2021 Feb; 22(1):170. PubMed ID: 33648563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]